Speculation9 Feb 2021 16:13
Surely it’s not the end of the world following this recent RNS? Yes, in an ideal world, the SPA would have been agreed and the share price bounced to £1 making us all rich in 24hrs but they never said it was guaranteed and was fairly unlikely. The Phase 3 trial is still going ahead which is what we expected albeit a relatively small delay in the scheme of things, the FDA are supporting a ‘final guidance’ meeting and have not said ‘this drug will never be approved’. The whole point of these trials and discussions with the FDA is to ensure the correct safety information is obtained along with efficacy details, ensuring a new drug delivered to the market is both safe and effective. Whilst none of us can guarantee that the drug will be approved, neither can any of us guarantee it won’t be approved. Stick to the facts....